SEC Form 4 · accession 0001437749-17-020657
Proto Labs Inc · PRLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Bodor
Officer — VP/General Manager-Americas
Period of report
Dec 11, 2017
Accepted (ET)
Dec 13, 2017 · 5:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001443669
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 11, 2017 | M | 4,000 | $36.41 | A | 20,578 | D | |
| Common StockF2 | Dec 11, 2017 | S | 4,000 | $94.787 | D | 16,578 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $36.41 | Dec 11, 2017 | M | 4,000 | D | — | Dec 11, 2022 | Common Stock | 4,000 | 0 | D |
Explanation of responses
- F1Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017.
- F2Reflects the weighted average price of 4,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on December 11, 2017 with sale prices ranging from $94.50 to $95.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Fully vested.